Exercise Training for Parkinson's Disease
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how different types of exercise can enhance cognitive function and sleep in people with Parkinson's disease. The study tests three exercise plans: delayed exercise training (a form of exercise rehabilitation), endurance training (aerobic exercise), and progressive resistance training (weightlifting). The goal is to determine if exercise can improve brain function and sleep quality, using slow wave sleep as a progress marker. People with Parkinson's disease who are not currently in an exercise program and have stable symptoms might be suitable for this trial. As an unphased trial, it offers participants the chance to contribute to groundbreaking research that could improve the quality of life for those with Parkinson's disease.
Will I have to stop taking my current medications?
The trial requires that you have been on stable medications for at least 4 weeks before joining and that you do not expect to change medications during the study.
What prior data suggests that exercise rehabilitation is safe for individuals with Parkinson's disease?
Research shows that Progressive Resistance Training (PRT) is generally safe for people with Parkinson's disease. Studies have found that PRT can improve muscle strength, movement, and quality of life without causing major side effects. Reports from various studies indicate that participants did not experience significant negative effects, making PRT a safe choice for those with Parkinson's.
Endurance Training (ET) is also considered safe for most people, including those with Parkinson's. It includes activities like walking or cycling, which are usually low-risk and beneficial for overall health. Most people handle endurance exercises well, with few reports of side effects.
Both types of exercise have been extensively studied, and research suggests they are safe and helpful for improving physical abilities in people with Parkinson's disease. Participants in these studies often report better strength and movement, with few negative effects.12345Why are researchers excited about this trial?
Researchers are excited about the exercise training for Parkinson’s disease because it explores how different types of exercise can improve symptoms in ways that standard medications might not. Progressive resistance training (PRT) is being studied for its potential to increase slow wave sleep, which is vital for recovery and brain health, possibly offering benefits beyond what medications like Levodopa or dopamine agonists provide. Endurance training (ET) and delayed exercise training (DE) are also being investigated for their ability to enhance physical and motor function, targeting the disease from a non-pharmaceutical angle. This approach could lead to more holistic management of Parkinson's, focusing on overall lifestyle and wellness.
What evidence suggests that these exercise treatments could be effective for Parkinson's disease?
Research has shown that progressive resistance training (PRT), which participants in this trial may receive, can greatly benefit people with Parkinson's disease. Studies have found that performing PRT 2-3 times a week significantly increases muscle strength and improves walking and balance. People with mild to moderate Parkinson's have reported a better quality of life and reduced freezing of gait after engaging in PRT. Additionally, aerobic exercises, included in the endurance training (ET) arm of this trial, have helped alleviate motor symptoms in Parkinson's patients. These exercises can play a crucial role in enhancing overall movement and well-being for those with the condition.26789
Who Is on the Research Team?
Amy Amara, MD, PhD
Principal Investigator
University of Colorado, Denver
Are You a Good Fit for This Trial?
This trial is for people aged 45 or older with Parkinson's Disease (PD) who can walk without help and have mild to moderate symptoms. They should be on stable PD meds, not expecting changes during the study, and score between 18-26 on a cognitive test. Those with serious heart conditions, other types of Parkinsonism, deep brain stimulation implants, untreated sleep disorders or those already doing regular exercise cannot join.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Treatment
Participants undergo 12 weeks of supervised progressive resistance training (PRT) 3 times per week
Follow-up Treatment
Responders to PRT continue with PRT for an additional 12 weeks, while non-responders transition to endurance training (ET)
Delayed Exercise
Participants in the delayed exercise group do not exercise for the first 12 weeks, then transition to PRT for the second 12 weeks
Follow-up
Participants are monitored for changes in cognition and slow wave sleep (SWS) after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Delayed Exercise Training (DE)
- Endurance Training (ET)
- Progressive Resistance Training (PRT)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
University of Colorado, Denver
Lead Sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Collaborator
National Institutes of Health (NIH)
Collaborator